References
- Laurie JA, Moertel CG, Fleming TR et al. Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. J Clin Oncol 1989: 7(10): 1447–56
- Moertel CG, Fleming TR, Macdonald JS, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 1990: 322(6): 352–8
- Wolmark N, Fisher B, Rockette H, et al. Postoperative adjuvant chemotherapy or BCG for colon cancer: results from NSABP protocol C-01. J Natl Cancer Inst 1988: 80(1): 30–6
- Panettiere FJ, Goodman PJ, Costanzi JJ, et al. Adjuvant therapy in large bowel adenocarcinoma: long-term results of a Southwest Oncology Group Study. J Clin Oncol 1988: 6(6): 947–54
- Gastrointestinal Tumor Study Group. Adjuvant therapy of colon cancer: results of a prospectively randomized trial. N Engl J Med 1984: 310(12): 737–43
- Higgins GA Jr, Amadeo JH, McElhinney J, et al. Efficacy of prolonged intermittent therapy with combined 5-fluorouracil and methyl-CCNU following resection for carcinoma of the large bowel: a Veterans Administration Surgical Oncology Group report. Cancer 1984: 53(1): 1–8
- Wittes RE. Progress in a desert: oasis or mirage? J Natl Cancer Inst 1988: 80(1): 5–7
- Verhaegen H, DeCree J, DeCock W, et al. Levamisole therapy in patients with colorectal cancer. In: Terry WD, Rosenberg SA eds. Immunotherapy of human cancer. New York: Elsevier Science Publishing, 1982: 225–9
- Update: the efficacy and the Group C status of levamisole and 5-fluorouracil for patients with Dukes' C colon cancer. Bethesda: National Cancer Institute, 1989